310 related articles for article (PubMed ID: 19323631)
1. Influenza virus resistance to antiviral agents: a plea for rational use.
Poland GA; Jacobson RM; Ovsyannikova IG
Clin Infect Dis; 2009 May; 48(9):1254-6. PubMed ID: 19323631
[TBL] [Abstract][Full Text] [Related]
2. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.
Stephenson I; Democratis J; Lackenby A; McNally T; Smith J; Pareek M; Ellis J; Bermingham A; Nicholson K; Zambon M
Clin Infect Dis; 2009 Feb; 48(4):389-96. PubMed ID: 19133796
[TBL] [Abstract][Full Text] [Related]
3. Oseltamivir resistance among influenza viruses: surveillance in northern Viet Nam, 2009-2012.
Hoang Vu MP; Nguyen CT; Nguyen le KH; Nguyen TK; Le QM
Western Pac Surveill Response J; 2013; 4(2):25-9. PubMed ID: 24015368
[TBL] [Abstract][Full Text] [Related]
4. Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.
Dharan NJ; Beekmann SE; Fiore A; Finelli L; Uyeki TM; Polgreen PM; Fry AM
Antiviral Res; 2010 Nov; 88(2):182-6. PubMed ID: 20739002
[TBL] [Abstract][Full Text] [Related]
5. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza.
Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A
Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654
[TBL] [Abstract][Full Text] [Related]
6. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.
Sheu TG; Deyde VM; Okomo-Adhiambo M; Garten RJ; Xu X; Bright RA; Butler EN; Wallis TR; Klimov AI; Gubareva LV
Antimicrob Agents Chemother; 2008 Sep; 52(9):3284-92. PubMed ID: 18625765
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.
Jonges M; van der Lubben IM; Dijkstra F; Verhoef L; Koopmans M; Meijer A
Antiviral Res; 2009 Sep; 83(3):290-7. PubMed ID: 19591877
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology and spread of drug resistant human influenza viruses.
Hurt AC
Curr Opin Virol; 2014 Oct; 8():22-9. PubMed ID: 24866471
[TBL] [Abstract][Full Text] [Related]
9. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
Ikematsu H; Kawai N
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
[TBL] [Abstract][Full Text] [Related]
10. Antivirals and influenza: frequency of resistance.
Monto AS
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
[TBL] [Abstract][Full Text] [Related]
11. Virological surveillance and antiviral resistance of human influenza virus in Argentina, 2005-2008.
Pontoriero A; Baumeister E; Campos AM; Savy VL
Rev Panam Salud Publica; 2011 Dec; 30(6):634-40. PubMed ID: 22358415
[TBL] [Abstract][Full Text] [Related]
12. Influenza virus susceptibility and resistance to oseltamivir.
Aoki FY; Boivin G; Roberts N
Antivir Ther; 2007; 12(4 Pt B):603-16. PubMed ID: 17944268
[TBL] [Abstract][Full Text] [Related]
13. Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010.
Cho HG; Choi JH; Lee HK; Mun SK; Lee JB; Jho EH; Kang C; Lim YH
Arch Virol; 2013 Nov; 158(11):2365-70. PubMed ID: 23690054
[TBL] [Abstract][Full Text] [Related]
14. Implications of antiviral resistance of influenza viruses.
Monto AS
Clin Infect Dis; 2009 Feb; 48(4):397-9. PubMed ID: 19586376
[No Abstract] [Full Text] [Related]
15. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.
Bright RA; Shay DK; Shu B; Cox NJ; Klimov AI
JAMA; 2006 Feb; 295(8):891-4. PubMed ID: 16456087
[TBL] [Abstract][Full Text] [Related]
16. Influenza drug resistance.
Pizzorno A; Abed Y; Boivin G
Semin Respir Crit Care Med; 2011 Aug; 32(4):409-22. PubMed ID: 21858746
[TBL] [Abstract][Full Text] [Related]
17. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA
Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593
[TBL] [Abstract][Full Text] [Related]
18. [Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models].
Leneva IA; Fediakina IT; Eropkin MIu; Gudova NV; Romanovskaia AA; Danilenko DM; Vinogradova SM; Lepeshkin AIu; Shestopalov AM
Vopr Virusol; 2010; 55(3):19-27. PubMed ID: 20608077
[TBL] [Abstract][Full Text] [Related]
19. In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.
Sleeman K; Mishin VP; Deyde VM; Furuta Y; Klimov AI; Gubareva LV
Antimicrob Agents Chemother; 2010 Jun; 54(6):2517-24. PubMed ID: 20350949
[TBL] [Abstract][Full Text] [Related]
20. Influenza antiviral resistance testing in new york and wisconsin, 2006 to 2008: methodology and surveillance data.
Laplante JM; Marshall SA; Shudt M; Van TT; Reisdorf ES; Mingle LA; Shult PA; St George K
J Clin Microbiol; 2009 May; 47(5):1372-8. PubMed ID: 19321726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]